Merck & Co Inc

NYSE:MRKUnited States

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, and health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3 (DLL3), an inhibitory canonical Notch ligand.

Contact Information

Headquarters

2000 Galloping Hill RoadKENILWORTH, NJ, United States 07033

Phone

908-740-4000

Fax

908-423-1987

Executives

Chairman of the Board, President, Chief Executive Officer

Robert Davis

Chief Financial Officer, Executive Vice President

Caroline Litchfield

Executive Vice President, Chief Human Resources Officer

Steven Mizell

Executive Vice President, Chief Information and Digital Officer

David Williams

Executive Vice President, General Counsel, Corporate Secretary

Jennifer Zachary